Reducing infection rates after prostate biopsy (Q38178006)

30 August 2017

Reducing infection rates after prostate biopsy (English)

1 reference

30 August 2017

0 references

Florian M E Wagenlehner

1

1 reference

30 August 2017

Adrian Pilatz

2

1 reference

30 August 2017

Przemyslaw Waliszewski

3

1 reference

30 August 2017

Wolfgang Weidner

4

1 reference

30 August 2017

Truls E Bjerklund Johansen

5

1 reference

30 August 2017

language of work or name

English

0 references

publication date

14 January 2014

1 reference

30 August 2017

Nature Reviews Urology

1 reference

30 August 2017

11

1 reference

30 August 2017

2

1 reference

30 August 2017

80-86

1 reference

https://scigraph.springernature.com/pub.10.1038/nrurol.2013.322

30 August 2017

0 references

cites work

Bacterial sepsis following prostatic biopsy.

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2013.322

Prevalence and significance of fluoroquinolone resistant Escherichia coli in patients undergoing transrectal ultrasound guided prostate needle biopsy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2013.322

Complications after prostate biopsy: data from SEER-Medicare

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2013.322

Infectious complications and hospital admissions after prostate biopsy in a European randomized trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2013.322

Preoperative assessment of the patient and risk factors for infectious complications and tentative classification of surgical field contamination of urological procedures

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2013.322

Infection after transrectal ultrasonography-guided prostate biopsy: increased relative risks after recent international travel or antibiotic use.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2013.322

Systematic review of complications of prostate biopsy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2013.322

Is it possible to predict sepsis, the most serious complication in prostate biopsy?

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2013.322

Infective complications after prostate biopsy: outcome of the Global Prevalence Study of Infections in Urology (GPIU) 2010 and 2011, a prospective multinational multicentre prostate biopsy study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2013.322

Is repeat prostate biopsy associated with a greater risk of hospitalization? Data from SEER-Medicare

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2013.322

Increasing hospital admission rates for urological complications after transrectal ultrasound guided prostate biopsy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2013.322

The feasibility of multiparametric magnetic resonance imaging for targeted biopsy using novel navigation systems to detect early stage prostate cancer: the preliminary experience

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2013.322

Morbidity after transperineal prostate biopsy in 3000 patients undergoing 12 vs 18 vs more than 24 needle cores

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2013.322

The national burden of infections after prostate biopsy in England and Wales: a wake-up call for better prevention

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2013.322

Early detection of prostate cancer: AUA Guideline

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2013.322

Increasing risk of infectious complications after transrectal ultrasound-guided prostate biopsies: time to reassess antimicrobial prophylaxis?

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2013.322

Escherichia coli bloodstream infection after transrectal ultrasound-guided prostate biopsy: implications of fluoroquinolone-resistant sequence type 131 as a major causative pathogen.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2013.322

Fluoroquinolone-resistant E. coli in intestinal flora of patients undergoing transrectal ultrasound-guided prostate biopsy--should we reassess our practices for antibiotic prophylaxis?

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2013.322

Travel-associated extended-spectrum β-lactamase-producing Escherichia coli bloodstream infection following transrectal ultrasound-guided prostate biopsy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2013.322

Emergence of fluoroquinolone-resistant Escherichia coli as cause of postprostate biopsy infection: implications for prophylaxis and treatment.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2013.322

Incidence, risk factors and outcomes of Escherichia coli bloodstream infections in a large Canadian region

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2013.322

Transrectal ultrasound-guided prostate biopsy: is antibiotic prophylaxis necessary?

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2013.322

Antibiotic prophylaxis in urologic procedures: a systematic review.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2013.322

Antimicrobial resistance trends of Escherichia coli bloodstream isolates: a population-based study, 1998-2007.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2013.322

Characterization of ciprofloxacin resistant Escherichia coli isolates among men undergoing evaluation for transrectal ultrasound guided prostate biopsy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2013.322

The role of antibiotics in chronic bacterial prostatitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2013.322

Antibiotic therapy - rationale and evidence for optimal drug concentrations in prostatic and seminal fluid and in prostatic tissue

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2013.322

Concentrations of cefpodoxime in plasma, ejaculate and in prostatic fluid and adenoma tissue

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2013.322

Determination of doripenem penetration into human prostate tissue and assessment of dosing regimens for prostatitis based on site-specific pharmacokinetic-pharmacodynamic evaluation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2013.322

Oral levofloxacin 500 mg once daily in the treatment of chronic bacterial prostatitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2013.322

Influence of a prophylactic single dose of ciprofloxacin on the level of resistance of Escherichia coli to fluoroquinolones in urology.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2013.322

Bisacodyl rectal preparation can decrease infectious complications of transrectal ultrasound-guided prostate biopsy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2013.322

A prospective randomized trial of povidone-iodine prophylactic cleansing of the rectum before transrectal ultrasound guided prostate biopsy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2013.322

Formalin disinfection of biopsy needle minimizes the risk of sepsis following prostate biopsy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2013.322

Optimal approach for prostate cancer detection as initial biopsy: prospective randomized study comparing transperineal versus transrectal systematic 12-core biopsy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2013.322

Complications of transrectal versus transperineal prostate biopsy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2013.322

The results of transperineal versus transrectal prostate biopsy: a systematic review and meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2013.322

Surviving sepsis campaign: international guidelines for management of severe sepsis and septic shock: 2012

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2013.322

Empiric antibiotic treatment and the misuse of culture results and antibiotic sensitivities in patients with community-acquired bacteraemia due to urinary tract infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2013.322

Surviving Sepsis Campaign: international guidelines for management of severe sepsis and septic shock, 2012

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2013.322

Targeted Antimicrobial Prophylaxis Using Rectal Swab Cultures in Men Undergoing Transrectal Ultrasound Guided Prostate Biopsy is Associated With Reduced Incidence of Postoperative Infectious Complications and Cost of Care

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2013.322

Antibiotic prophylaxis for transrectal prostate biopsy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2013.322

Increasing hospital admission rates for urological complications after transrectal ultrasound guided prostate biopsy

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2013.322

Single-Dose Antibiotic Prophylaxis in Core Prostate Biopsy: Impact of Timing and Identification of Risk Factors

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2013.322

EAU guidelines on prostate cancer. Part II: Treatment of advanced, relapsing, and castration-resistant prostate cancer.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2013.322

The responsible use of antibiotics for an elevated PSA level

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2013.322

Infection after transrectal ultrasonography-guided prostate biopsy: increased relative risks after recent international travel or antibiotic use

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2013.322

[Antibiotic prophylaxis in urology]

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2013.322

Resistance patterns of nosocomial urinary tract infections in urology departments: 8-year results of the global prevalence of infections in urology study

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2013.322

Ciprofloxacin versus gentamicin in prophylaxis against bacteremia in transrectal prostate needle biopsy

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2013.322

The penetration of antibiotics into the prostate in chronic bacterial prostatitis

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2013.322

Diffusion of piperacillin, cefotiam, minocycline, amikacin and ofloxacin into the prostate

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2013.322

Prostatic penetration of meropenem in humans, and dosage considerations for prostatitis based on a site-specific pharmacokinetic/pharmacodynamic evaluation

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2013.322

Concentrations of trimethoprim and sulphamethoxazole in the human prostate gland after intramuscular injection

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2013.322

The effectiveness of single-dose fosfomycin as antimicrobial prophylaxis for patients undergoing transrectal ultrasound-guided biopsy of the prostate

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2013.322

Antimicrobial therapy for chronic bacterial prostatitis

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2013.322

Diagnosis and management for urosepsis

31 March 2020

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/24418806

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

[Concentration of antimicrobial agents in male genital organs]

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/24418806

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Identifiers

DOI

10.1038/NRUROL.2013.322

1 reference

Dimensions Publication ID

30 August 2017

0 references

1 reference